Latest News

3 EV Makers With Big Plans for 2022

0

Electric vehicle (EV) maker Rivian Automotive Inc. (Nasdaq: RIVN) has gotten a ton of hype this year.AC

Its valuation soared to over $150 billion at one point.

Part of that enthusiasm is due to Rivian’s upcoming R1S electric SUV.

The first deliveries should start around March.

But the R1S is far from the only major EV launch in the near future.

Here are a few upcoming EVs that you need to pay attention to…

Vietnam Has an EV Startup

Vietnam isn’t known for its cars.

But one Vietnamese automaker is hoping to make a huge splash in the global EV market.

Billionaire Pham Nhat Vuong, Vietnam’s richest person, founded VinFast in 2017.

The first batch of its VF e34 should arrive in Vietnam by Christmas Day.

The company said it has already received 25,000 orders for the electric SUV.

But the e34 is just the beginning for the fledgling automaker.

Last month, it unveiled the e35 and e36 at the Los Angeles Auto Show.

VinFast will start taking preorders in the U.S. for its new cars by mid-2022.

VinFast hasn’t released prices for its new models yet. But it suggested they could be more affordable than competitors’ products.

The company is also planning for a big stock market debut in late 2022.

It expects a valuation of around $60 billion.

That’s higher than most Asian automakers, including Honda, Hyundai and Kia.

Polestar’s Triple Threat

I wrote about Polestar last month.

The automaker is a subsidiary of Volvo and the Chinese company Geely.

After we published the article, Polestar released new info about its upcoming models.

The Polestar 3 is an electric SUV that will arrive in the U.S. around late 2022.

It has five seats and should cost around $80,000.

The Polestar 4 is still a bit of a mystery.

But it’s supposed to be a smaller, cheaper version of the Polestar 3.

It will likely cost around $50,000.

Good news, though: I have a new image of the Polestar 5.

This EV will serve as Polestar’s flagship model.

It’s supposed to compete with other electric luxury sedans such as the Tesla Model S.

The Polestar 5 has dual motors and other premium features. So, it will probably cost about $100,000.

The car should launch sometime in 2024.

Polestar plans to go public in a few months with a valuation of only $20 billion.

Don’t Forget About Tesla

Tesla Inc. (Nasdaq: TSLA) released its “Cyberquad for Kids” earlier this month.

The small electric all-terrain vehicle costs $1,900, and it sold out immediately.

The toy is just a novelty. But there’s a real Cyberquad in the works.

Tesla CEO Elon Musk unveiled a prototype in 2019.

The Cyberquad seats two people. It should start production in late 2022.

We don’t know how much it’ll cost yet. But you can bet it will be a lot more than $1,900.

Last but not least, Tesla’s long-awaited Cybertruck will also come out in late 2022.

The futuristic electric truck already has over 1 million preorders.

The Cybertruck will seat six people and come in three versions:

As you can see in the chart, the tri-motor version has a range of over 500 miles.

That’s better than any Tesla model currently on the market.

The base model only costs $40,000.

It’s $50,000 for dual motors, and the tri-motor version is $70,000.

Of course, not everyone is a fan of the Cybertruck’s design.

Do you like the Cybertruck? Or do you think it’s ugly? You can let us know at WinningInvestorDaily@BanyanHill.com.

The Best Way to Play the EV Boom

VinFast, Polestar and Tesla all have impressive EVs.

So, it’s too early to tell which company’s stock will be the biggest winner in the long run.

That’s why Ian King recommends “a pick-and-shovel play on EVs” instead.

His New Era Fortunes portfolio has a tiny company that makes something every EV can use.

Most investors haven’t heard of this company yet.

But Ian believes it has the potential to soar as much as 1,000%.

If you haven’t subscribed to New Era Fortunes yet, then click here to watch Ian’s new presentation.

Regards,

Jay Goldberg

Assistant Managing Editor, Banyan Hill Publishing

 

Morning Movers


From open till noon Eastern time.

 

Yankuang Energy Group Company Ltd. (OTC: YZCAY) engages in the mining, preparation and sale of coal worldwide. The stock jumped 23% after the company unveiled plans to expand its coal-mining business while diversifying into new-energy power generation and other minerals.

 

WuXi Biologics (Cayman) Inc. (OTC: WXXWY) is a Chinese biotech platform-technology company that is up 18% on a rebound. The stock initially sank 20% Wednesday on fears that the U.S. will soon announce investment and export sanctions against Chinese biotechs.<

 

Zai Lab Ltd. (Nasdaq: ZLAB) develops therapies for oncology, autoimmune disorders and infectious diseases in China. It is up 16% today partially for the same reason as WuXi Biologics, and partially because the China National Medical Products Administration approved its New Drug Application for a novel antibiotic treatment.

 

Valneva SE (Nasdaq: VALN), the French vaccine maker, is up 15% this morning. The move came after the company announced that its COVID-19 vaccine candidate was efficient as a booster for people who had received the same shot as an initial vaccination.

 

Smoore International Holdings Ltd. (OTC: SMORF) designs and manufactures vaping devices and vaping components for tobacco companies. It is up 14% after one of its brands, VAPORESSO, unveiled its new line of vaping products at the Shenzhen IECIE, one of the most influential e-cigarette expos in the world.

 

CIMC Enric Holdings Ltd. (OTC: CIMEF) is a Chinese logistics and energy equipment supplier. It is up 10% after it announced that its operating revenue hit a historical high in the first three quarters of the year, putting it on track to become the latest member of Shenzhen’s “100-billion-yuan business club.”

 

BeiGene Ltd. (Nasdaq: BGNE) discovers, develops and manufactures medicines for cancer treatments in China. It is another biotech that fell initially on fears of imminent sanctions on Chinese biotechs by the U.S. government. The stock rebounded 9% today.

 

Vir Biotechnology Inc. (Nasdaq: VIR) is an immunology company that develops therapeutics to treat and prevent serious infectious diseases. It is up 8% continuing its momentum from Wednesday when preclinical data showed that its COVID-19 drug remained effective against the omicron variant.

 

Pan American Silver Corp. (Nasdaq: PAAS) is a silver, gold, zinc, lead and copper miner that operates in North and South America. It is up 8% after the Province of Chubut in Argentina approved a bill permitting open pit mining in certain zones. This would benefit the company’s mining operations in those zones.

 

Customers Bancorp Inc. (NYSE: CUBI), the bank, is up 8% this morning, hitting a new 52-week high. The stock is continuing on the momentum from earlier in the week when analysts at B. Riley raised their price target on the stock.

A Big Lithium-Ion Battery Order Was Just Placed. It’s Not for EVs.

Previous article

Fauci says omicron will soon become dominant Covid variant in U.S., urges people to get shots

Next article

You may also like

Comments

Leave a reply

Your email address will not be published.

More in Latest News